Analysts Viewpoint
Vanda Pharmaceuticals Inc [VNDA] Shares Fall Approximately -14.26% Over the Year
Investors can expect a company’s stock to rise or fall based on the buying and selling of stock by its
Menu
Investors can expect a company’s stock to rise or fall based on the buying and selling of stock by its
Vanda Pharmaceuticals Inc’s recent filing unveils that its President and CEO Polymeropoulos Mihael Hristos acquired Company’s shares for reported $50150.0
Vanda Pharmaceuticals Inc’s recent filing unveils that its President and CEO Polymeropoulos Mihael Hristos acquired Company’s shares for reported $50150.0
Vanda Pharmaceuticals Inc’s recent filing unveils that its President and CEO Polymeropoulos Mihael Hristos acquired Company’s shares for reported $50150.0
Vanda Pharmaceuticals Inc. (NASDAQ:VNDA) does about 670.95K shares in volume on a normal day but saw 493956 shares change hands